Economy of scale ,, CHM is to small on its own ,,, merged in with IMU it adds tremendous weight in the Oncology Sector,, Hopper may well be creating a Mega Oncology Company ... Reducing staff levels , running down the cash plus a placement that's eye watering ,,which is all by design not accident, the one thing for sure is in the next month we will all know exactly what the future holds for CHM ,,, Hoping we all get a Premium ....
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive, page-15
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.776M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.73K | 1.077M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 5624045 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 3249484 | 8 |
View Market Depth
| Last trade - 14.35pm 01/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |